The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108 18,176 1,111,030 SH   SOLE   1,111,030 0 0
AFTERNEXT HEALTHTECH ACQUISITION CORP *W EXP 99/99/999 G01109126 59 366,666 SH   SOLE   366,666 0 0
ALGOMA STL GROUP INC COM 015658107 23,936 3,716,732 SH   SOLE   3,716,732 0 0
AMICUS THERAPEUTICS INC COM 03152W109 17,627 1,688,400 SH   SOLE   1,688,400 0 0
APELLIS PHARMACEUTICALS INC COM 03753U106 18,174 266,090 SH   SOLE   266,090 0 0
ARCUS BIOSCIENCES INC COM 03969F109 16,915 646,586 SH   SOLE   646,586 0 0
ARES ACQUISITION CORP *W EXP 99/99/999 G33032122 58 504,706 SH   SOLE   504,706 0 0
ARGENX SE SPONSORED ADR 04016X101 10,157 28,770 SH   SOLE   28,770 0 0
ARVINAS INC COM 04335A105 17,752 399,000 SH   SOLE   399,000 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101 12,742 123,400 SH   SOLE   123,400 0 0
BERENSON ACQUISITION CORP I *W EXP 08/01/202 083690115 44 862,499 SH   SOLE   862,499 0 0
BILANDER ACQUISITION CORP *W EXP 05/19/202 09001T114 36 183,749 SH   SOLE   183,749 0 0
BRIDGETOWN HOLDINGS LTD *W EXP 09/30/202 G1355U121 116 895,000 SH   SOLE   895,000 0 0
CATALYST PARTNERS ACQUISITION *W EXP 05/12/202 G19550121 37 336,666 SH   SOLE   336,666 0 0
CEREVEL THERAPEUTICS HLDNG I COM 15678U128 15,173 536,901 SH   SOLE   536,901 0 0
CHURCHILL CAPITAL CORP V *W EXP 10/29/202 17144T115 52 612,000 SH   SOLE   612,000 0 0
CHURCHILL CAPITAL CORP VI *W EXP 02/17/202 17143W119 76 540,000 SH   SOLE   540,000 0 0
CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110 74 548,000 SH   SOLE   548,000 0 0
COHN ROBBINS HOLDINGS CORP *W EXP 08/28/202 G23726113 21 904,000 SH   SOLE   904,000 0 0
COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123 41 459,906 SH   SOLE   459,906 0 0
CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116 86 408,333 SH   SOLE   408,333 0 0
CONYERS PARK III ACQUISITION CORP *W EXP 08/12/202 21289P110 104 571,666 SH   SOLE   571,666 0 0
CORSAIR PARTNERING CORP *W EXP 07/06/202 G2540H116 28 334,666 SH   SOLE   334,666 0 0
CYTOKINETICS INC COM NEW 23282W605 18,449 380,793 SH   SOLE   380,793 0 0
DISH NETWORK CORPORATION NOTE 12/1 25470MAF6 13,220 20,000,000 PRN   SOLE   20,000,000 0 0
FIRST LIGHT ACQUISITION GROUP INC *W EXP 03/14/202 320703119 37 655,200 SH   SOLE   655,200 0 0
FORTRESS CAPITAL ACQUISITION C *W EXP 99/99/999 G36427121 31 392,000 SH   SOLE   392,000 0 0
FORTRESS VALUE ACQUISITION COR *W EXP 12/31/202 34964G115 23 225,000 SH   SOLE   225,000 0 0
FORTRESS VALUE ACQUISITION COR *W EXP 03/18/202 34964K116 54 306,513 SH   SOLE   306,513 0 0
GALAPAGOS NV SPON ADR 36315X101 16,190 379,702 SH   SOLE   379,702 0 0
GLOBAL BUSINESS TRAVEL GROUP *W EXP 99/99/9999 37890B118 1,433 913,000 SH   SOLE   913,000 0 0
GORES TECHNOLOGY PARTNERS II INC *W EXP 03/16/202 38287L115 72 450,691 SH   SOLE   450,691 0 0
GORES TECHNOLOGY PARTNERS INC *W EXP 03/16/202 382870111 38 201,000 SH   SOLE   201,000 0 0
HEALTH ASSURANCE ACQUISITION C *W EXP 11/12/202 42226W117 19 643,000 SH   SOLE   643,000 0 0
HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111 17 690,000 SH   SOLE   690,000 0 0
IOVANCE BIOTHERAPEUTICS INC COM 462260100 15,194 1,586,043 SH   SOLE   1,586,043 0 0
IVERIC BIO INC COM 46583P102 17,718 987,600 SH   SOLE   987,600 0 0
JAWS HURRICANE ACQUISITION CORP *W EXP 03/26/202 47201B111 65 387,249 SH   SOLE   387,249 0 0
KKR ACQUISITION HOLDINGS I CORP *W EXP 99/99/999 48253T117 71 588,547 SH   SOLE   588,547 0 0
LEVERE HOLDINGS CORP *W EXP 03/09/202 G5462L122 14 274,999 SH   SOLE   274,999 0 0
MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113 16 735,000 SH   SOLE   735,000 0 0
MUSIC ACQUISITION CORP/THE *W EXP 02/05/202 62752R118 3 75,250 SH   SOLE   75,250 0 0
PROTHENA CORP PLC SHS G72800108 18,516 305,400 SH   SOLE   305,400 0 0
REVOLUTION HEALTHCARE ACQUISIT *W EXP 12/31/202 76155Y116 17 432,639 SH   SOLE   432,639 0 0
ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114 34 439,666 SH   SOLE   439,666 0 0
SAGE THERAPEUTICS INC COM 78667J108 16,812 429,313 SH   SOLE   429,313 0 0
SENIOR CONNECT ACQUISITION COR *W EXP 12/31/202 81723H116 10 1,014,000 SH   SOLE   1,014,000 0 0
SIMON PROPERTY GROUP ACQUISITION HOLDINGS INC *W EXP 02/04/202 82880R111 22 335,200 SH   SOLE   335,200 0 0
SKYDECK ACQUISITION CORP *W EXP 05/13/202 G82220115 42 361,756 SH   SOLE   361,756 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107 8,790 308,092 SH   SOLE   308,092 0 0
STARRY GROUP HOLDINGS INC *W EXP 99/99/999 85572U110 87 669,000 SH   SOLE   669,000 0 0
SUMMIT HEALTHCARE ACQUISITION CORP *W EXP 06/03/202 G8566R110 74 489,999 SH   SOLE   489,999 0 0
SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111 25 490,000 SH   SOLE   490,000 0 0
TRAVERE THERAPEUTICS INC COM 89422G107 25,351 1,028,875 SH   SOLE   1,028,875 0 0
WARBURG PINCUS CAPITAL CORP I-A *W EXP 99/99/999 G9461D115 1 14,999 SH   SOLE   14,999 0 0
WARBURG PINCUS CAPITAL CORP I-B *W EXP 99/99/999 G9460M124 8 125,000 SH   SOLE   125,000 0 0
ZIMMER ENERGY TRANSITION ACQUISITION CORP *W EXP 06/16/202 989570114 111 358,270 SH   SOLE   358,270 0 0